Feb, 06 2023

CRESCITA THERAPEUTICS INC, GSK plc, Agile Therapeutics가 2022년 북미 국소 약물 전달 시장을 장악했습니다.

북미 국소 약물 전달 시장은 2023년부터 2030년까지의 예측 기간 동안 6.8%의 CAGR로 성장할 것으로 예상됩니다. 연구에 고려된 연도는 아래와 같습니다.

전체 보고서는 https://www.databridgemarketresearch.com/reports/north-america-topical-drug-delivery-market 에서 확인하세요.

북미 국소 약물 전달 시장은 특정 수의 주요 기업들이 참여하는 고도로 통합된 시장입니다. 시장 상황이 호전됨에 따라 전략적 개발이 활발하게 진행되고 있습니다.

북미 국소 약물 전달 시장의 주요 기업들은 다양한 용도를 가진 강력한 제품군을 출시하고 있으며, 발표, 성과, 혁신 등 전략적 이니셔티브를 시장에 도입하고 있습니다. 이를 통해 기업들은 향상된 서비스 포트폴리오를 통해 매출을 극대화할 수 있었습니다.

예를 들어,

2021년 6월, 성장 지향적이고 혁신을 주도하는 캐나다 상업 피부과 회사인 Crescita Therapeutics Inc.는 의료 미용, 안과 및 정형외과 분야를 전문으로 하는 세계적으로 인정받는 제약 회사인 Croma Pharma GmbH와 독일, 영국, 아일랜드, 스위스, 브라질, 루마니아, 벨기에, 네덜란드 및 룩셈부르크를 포함한 9개국에서 Pliaglis에 대한 권리를 위한 독점적 상용화 및 개발 라이선스 계약을 체결했다고 발표했습니다.

Crescita Therapeutics Inc는 북미 국소 약물 전달 시장의 선두 기업입니다. 이 시장의 다른 주요 기업으로는 GSK plc., Agile Therapeutics, Pfizer Inc., AbbVie Inc., Viatris Inc., Bayer AG, Procter & Gamble, 3M, Merck & Co., Inc., Bausch Health Companies Inc., Novartis AG, Hisamitsu Pharmaceutical Co.,Inc., Glenmark Pharmaceuticals US Inc., Cipla Inc., Purdue Pharma LP, Noven Pharmaceuticals, Inc., ANI Pharmaceuticals, Inc., NITTO DENKO CORPORATION., Tapemark, tesa Labtec GmbH, LTS Lohmann Therapie-Systeme AG, Medherant Limited 등이 있습니다.

크레시타 테라퓨틱스 주식회사

크레시타 테라퓨틱스(Crescita Therapeutics Inc)는 캐나다 온타리오주에 본사를 두고 있으며 2016년에 설립되었습니다. 주식회사입니다. 이 회사는 피부 질환, 질병 및 증상의 치료와 관리를 위한 처방 및 일반 의약품 포트폴리오를 제공하는 데 중점을 두고 있습니다. 상업용 스킨케어, 라이선싱 및 로열티, 제조 및 서비스 등의 사업 부문을 운영하고 있으며, 이 중 상업용 스킨케어가 시장 중심 분야입니다. 일반의약품(일반의약품 및 병원용)과 처방전 제품 등의 제품 카테고리를 운영하고 있으며, 이 중 일반의약품(일반의약품 및 병원용)과 처방전 제품이 시장 중심 분야입니다.

예를 들어,

In June 2021, Crescita Therapeutics Inc. a growth-oriented, innovation-driven Canadian commercial dermatology company, announced that it has entered into an exclusive commercialization and development license agreement with Croma Pharma GmbH, a globally acclaimed pharmaceutical company with specializations in medical aesthetics, ophthalmology and orthopedics for the rights to Pliaglis in nine countries including Germany, the United Kingdom, Ireland, Switzerland, Brazil, Romania, Belgium, the Netherlands and Luxembourg

The company has a presence in North America.

GSK plc.

GSK plc. is headquartered in London, in the U.K., and was founded in 1715. It has public ownership. The company focuses on innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. The company has business segments such as Pharmaceuticals, Vaccines, Consumer Healthcare, out of which pharmaceuticals is the market-focused segment. The company has product categories such as Vaccines, Specialty Medicines, General Medicines, out of which general medicines is the market-focused category.

For instance,

In December 2022, GSK plc announced new 48-week data from the MOMENTUM phase III trial that showed a majority of patients treated with investigational momelotinib maintained their responses across key clinical measures including Total Symptom Score (TSS), Transfusion Independence (TI) rate, and Splenic Response Rate (SRR) in myelofibrosis patients previously treated with an approved Janus kinase (JAK) inhibitor. Additionally, new analyses from MOMENTUM showed that TI response with momelotinib at week 24 was associated with overall survival

The company has a wide presence in the Americas, Europe, the Middle East and Africa, and Asia-Pacific. The company has subsidiaries such as Action Potential Venture Capital Limited (Canada), Adechsa GmbH (Switzerland), Allen & Hanburys Pharmaceutical Nigeria Limited (Nigeria), Beecham Group p.l.c (England), Beecham Pharmaceuticals (Pte) Limited (Singapore) among others.

Agile Therapeutics

Agile Therapeutics is headquartered in New Jersey, U.S., and was founded in 1997. It has public ownership. The company focuses on fulfilling the unmet needs of today’s women. The product category is Twirla.

For instance,

In January 2022, Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced a new alliance with Afaxys Pharma, LLC to promote Twirla (levonorgestrel and ethinyl estradiol) transdermal system

The company has a presence in America.

CHOOSE LICENCE TYPE

Enterprise User 7000
Single User 4800
DBMR Factbook 3000
DBMR Prime 8000
DBMR Nucleus 12000

Buy Now

Advance Formative Research Customization Request for bulk Reports

Latest Press Release

Expanding FPC Adoption in Automotive and Medical Electronics is Expected to Drive the Market

Rising Prevalence of Chronic Diseases is the Driving Factor in the Market

Growing Focus on Nuclear Fusion Research Drives Soft Magnetic Material Demand

Growing Demand for Packaged Beverages, Pharmaceuticals, and Personal Care Products

Rising Demand for Packaged and Convenience Food Products, Supported by Rapid Urbanization and Lifestyle Changes, is Driving the Growth of the Global Flexible Packaging Market

Rising Demand for Antioxidants in Processed Food and Beverages is the Driving Factor in the Market

VIEW ALL

Client Testimonials

Claudio Rondena

Group Business Development & Strategic Marketing Director,
C.O.C Farmaceutici SRL

"This morning we were involved in the first part, the data presentation of MKT analysis, selected abstract from your work. The board team was really impressed and very appreciated, as well."

David Manning - Thermo Fisher Scientific

Director, Global Strategic Accounts,

Dear Ricky,
I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.

Manager - Market Analytics,

Uriah D. Avila - Zeus Polymer Solutions

Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.

Business Development Manager,

(Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC

DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.

Business Intelligence and Analytics,

Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Competition Analyst,

Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Marketing Director,

Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

COO,

A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Marketing Director,

Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Product manager,

Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Investor relations,

GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Market Analyst,

Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Andrew - Senior Global Marketing Manager,

Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Amarildo - Manager, Global Strategic Alignment

MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Tor Hammer

Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Tommaso Finocchiaro

Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Yuki Kopyl (Asian Business Development Department)

UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future